Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG
Authors
Othus, M.Thomas, I.
Wang, X.
Ariti, C.
Mehta, P.
Sydenham, M.
Hills, R. K.
Burnett, A. K.
Nand, S.
Assouline, S.
Michaelis, L. C.
Erba, H. P.
Russell, N.
Kerr, K. F.
Walter, R. B.
Dennis, Michael
Affiliation
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USAIssue Date
2022
Metadata
Show full item recordAbstract
NoneCitation
Othus M, Thomas I, Wang X, Ariti C, Mehta P, Sydenham M, et al. Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG. Leuk Lymphoma. 2022 Oct 13:1-3. PubMed PMID: 36226777. Epub 2022/10/14. eng.Journal
Leukemia and LymphomaDOI
10.1080/10428194.2022.2131416PubMed ID
36226777Additional Links
https://dx.doi.org/10.1080/10428194.2022.2131416Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1080/10428194.2022.2131416
Scopus Count
Collections
Related articles
- Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.
- Authors: Ostronoff F, Othus M, Lazenby M, Estey E, Appelbaum FR, Evans A, Godwin J, Gilkes A, Kopecky KJ, Burnett A, List AF, Fang M, Oehler VG, Petersdorf SH, Pogosova-Agadjanyan EL, Radich JP, Willman CL, Meshinchi S, Stirewalt DL
- Issue date: 2015 Apr 1
- [Cytogenetic risk categories in acute myeloid leukemia: a comparison between MRC (Medical Research Council) and SWOG (Southwest Oncology Group) models)].
- Authors: Martín Ramos ML, López Pastor M, de la Serna Torroba J, Ayala R, García Alonso L, Barreiro Miranda E
- Issue date: 2003 Jun 28
- Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI.
- Authors: Othus M, van Putten W, Lowenberg B, Petersdorf SH, Nand S, Erba H, Appelbaum F, Hills R, Russell N, Burnett A, Estey E
- Issue date: 2016 Jul
- Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center.
- Authors: Walter RB, Othus M, Burnett AK, Löwenberg B, Kantarjian HM, Ossenkoppele GJ, Hills RK, Ravandi F, Pabst T, Evans A, Pierce SR, Vekemans MC, Appelbaum FR, Estey EH
- Issue date: 2015 Feb
- Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
- Authors: Chanswangphuwana C, Polprasert C, Owattanapanich W, Kungwankiattichai S, Tantiworawit A, Rattanathammethee T, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Nakhakes C, Prayongratana K, Sriswasdi C
- Issue date: 2022 Dec